Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | COMT | P21964 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5280107 | 0.75 | — | — | |
| SCHEMBL4614336 | 0.74 | SMN1; SMN2 (0.35) | SMN1; SMN2NOTUMALDH1A1 | |
| SCHEMBL5708467 | 0.74 | KMT2A (0.40) | MAPTSMN1; SMN2NOTUMCOMTALDH1A1 | |
| SCHEMBL5283936 | 0.68 | RAB9A (0.35) | MAPTNOTUMCOMTALDH1A1 | |
| SCHEMBL5289207 | 0.68 | RAB9A (0.35) | MAPTNOTUMCOMTALDH1A1 | |
| SCHEMBL5284328 | 0.66 | KDM4E (0.34) | MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL4621654 | 0.64 | DDB1 (0.44) | MAPTSMN1; SMN2NOTUMCOMTALDH1A1 | |
| SCHEMBL5281385 | 0.62 | KCNQ3 (0.46) | MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL5283985 | 0.59 | GPR3 (0.38) | MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL22795386 | 0.55 | SIGMAR1 (0.42) | MAPTSMN1; SMN2NOTUMCOMTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599178-B1 | MEANS AND METHOD FOR DYEING KERATIN FIBRES | WELLA AG (DE) | 2007-12-19 | — | — | EP | disclosed |
| US-7294151-B2 | Means and method for dyeing keratin fibres | WELLA AG (DE) | 2007-11-13 | — | — | US | disclosed |
| US-20060070190-A1 | Means and method for dyeing keratin fibres | KOYO SEIKO CO., LTD. (JP) | 2006-04-06 | — | — | US | disclosed |
| EP-1599178-A1 | MEANS AND METHOD FOR DYEING KERATIN FIBRES | Wella Aktiengesellschaft (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004078151-A1 | MEANS AND METHOD FOR DYEING KERATIN FIBRES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060070190-A1 | Means and method for dyeing keratin fibres | KRT18, KLK5, KIT | MAPT 1807/4885SMN1; SMN2 3523/4885NOTUM 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.